Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Regencell Bioscience Holdings Limited Ordinary Shares stock | $17

Learn how to easily invest in Regencell Bioscience Holdings Limited Ordinary Shares stock.

Regencell Bioscience Holdings Limited Ordinary Shares
NASDAQ: RGC - USD
DRUG MANUFACTURERS-SPECIALTY & GENERIC
$17.00
- $1.09 ( - 6.03%)

Regencell Bioscience Holdings Limited Ordinary Shares is a drug manufacturers-specialty & generic business based in the US. Regencell Bioscience Holdings Limited Ordinary Shares shares (RGC) are listed on the NASDAQ and all prices are listed in US Dollars.

How to buy shares in Regencell Bioscience Holdings Limited Ordinary Shares

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – RGC – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Regencell Bioscience Holdings Limited Ordinary Shares stock price (NASDAQ: RGC)

Use our graph to track the performance of RGC stocks over time.

Regencell Bioscience Holdings Limited Ordinary Shares shares at a glance

Information last updated 2021-10-21.
Latest market close$17.00
52-week range$6.00 - $59.00
50-day moving average $21.75
200-day moving average $17.66
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.09

Buy Regencell Bioscience Holdings Limited Ordinary Shares shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Robinhood
Robinhood
Stocks, Options, ETFs, Cryptocurrency
$0
0%
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
0%
N/A
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
N/A
$20 per year
N/A
Financial advice powered by relationships, not commissions.
TradeStation
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
$50
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
N/A
0%
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Moomoo
Stocks
$0
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Regencell Bioscience Holdings Limited Ordinary Shares stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Regencell Bioscience Holdings Limited Ordinary Shares price performance over time

Historical closes compared with the close of $17 from 2021-10-21

1 week (2021-10-15) -8.80%
1 month (2021-09-22) -17.68%
3 months (2021-07-22) 87.64%
6 months (2021-04-18) N/A
1 year (2020-10-18) N/A
2 years (2019-10-18) N/A
3 years (2018-10-18) N/A
5 years (2016-10-18) N/A

Regencell Bioscience Holdings Limited Ordinary Shares financials

Gross profit TTM $0
Return on assets TTM 0%
Return on equity TTM 0%
Profit margin 0%
Book value N/A
Market capitalisation $212.6 million

TTM: trailing 12 months

Shorting Regencell Bioscience Holdings Limited Ordinary Shares shares

There are currently 25,120 Regencell Bioscience Holdings Limited Ordinary Shares shares held short by investors – that's known as Regencell Bioscience Holdings Limited Ordinary Shares's "short interest". This figure is 45% down from 45,697 last month.

There are a few different ways that this level of interest in shorting Regencell Bioscience Holdings Limited Ordinary Shares shares can be evaluated.

Regencell Bioscience Holdings Limited Ordinary Shares's "short interest ratio" (SIR)

Regencell Bioscience Holdings Limited Ordinary Shares's "short interest ratio" (SIR) is the quantity of Regencell Bioscience Holdings Limited Ordinary Shares shares currently shorted divided by the average quantity of Regencell Bioscience Holdings Limited Ordinary Shares shares traded daily (recently around 418666.66666667). Regencell Bioscience Holdings Limited Ordinary Shares's SIR currently stands at 0.06. In other words for every 100,000 Regencell Bioscience Holdings Limited Ordinary Shares shares traded daily on the market, roughly 60 shares are currently held short.

To gain some more context, you can compare Regencell Bioscience Holdings Limited Ordinary Shares's short interest ratio against those of similar companies.

However Regencell Bioscience Holdings Limited Ordinary Shares's short interest can also be evaluated against the total number of Regencell Bioscience Holdings Limited Ordinary Shares shares, or, against the total number of tradable Regencell Bioscience Holdings Limited Ordinary Shares shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Regencell Bioscience Holdings Limited Ordinary Shares's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Regencell Bioscience Holdings Limited Ordinary Shares shares in existence, roughly 0 shares are currently held short) or 0.0124% of the tradable shares (for every 100,000 tradable Regencell Bioscience Holdings Limited Ordinary Shares shares, roughly 12 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Regencell Bioscience Holdings Limited Ordinary Shares.

Find out more about how you can short Regencell Bioscience Holdings Limited Ordinary Shares stock.

Regencell Bioscience Holdings Limited Ordinary Shares share dividends

We're not expecting Regencell Bioscience Holdings Limited Ordinary Shares to pay a dividend over the next 12 months.

Regencell Bioscience Holdings Limited Ordinary Shares overview

Regencell Bioscience Holdings Limited operates a traditional Chinese medicine (TCM) bioscience company. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong. .

Frequently asked questions

What percentage of Regencell Bioscience Holdings Limited Ordinary Shares is owned by insiders or institutions?
Currently 79.756% of Regencell Bioscience Holdings Limited Ordinary Shares shares are held by insiders and 0.053% by institutions.
When does the fiscal year end for Regencell Bioscience Holdings Limited Ordinary Shares?
Regencell Bioscience Holdings Limited Ordinary Shares's fiscal year ends in June.

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site